Assenagon Asset Management S.A. Lowers Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Assenagon Asset Management S.A. lowered its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 46.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 315,560 shares of the company’s stock after selling 268,979 shares during the quarter. Assenagon Asset Management […]

Related Keywords

United States ,Neurocrine Biosciences ,Darin Lippoldt ,Kyle Gano ,Jpmorgan Chase Co ,Redhawk Wealth Advisors Inc ,Nasdaq ,Canaccord Genuity Group ,Lisanti Capital Growth ,Barclays ,Securities Exchange Commission ,Neurocrine Biosciences Inc ,Guggenheim Capital ,Free Report ,Wealth Advisors ,Investment Management ,Get Free Report ,Exchange Commission ,Genuity Group ,Visit Holdingschannel ,Neurocrine Biosciences Daily ,